Cited by 180Venous Thromboembolism Diagnosis and ManagementAssisted Reproductive Technology and Twin PregnancyReproductive Health and Technologies

Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study

Open access
Henriksson, P., Westerlund, E., Wallen, H., Brandt, L., Hovatta, O., Ekbom, A.·2013·BMJ

Abstract

OBJECTIVE: To estimate the risk of pulmonary embolism and venous thromboembolism in pregnant women after in vitro fertilisation. DESIGN: Cross sectional study. SETTING: Sweden. PARTICIPANTS: 23,498 women who had given birth after in vitro fertilisation between 1990 and 2008 and 116,960 individually matched women with natural pregnancies. MAIN OUTCOME MEASURES: Risk of pulmonary embolism and venous thromboembolism (identified by linkage to the Swedish national patient register) during the whole pregnancy and by trimester. RESULTS: Venous thromboembolism occurred in 4.2/1000 women (n=99) after in vitro fertilisation compared with 2.5/1000 (n=291) in women with natural pregnancies (hazard ratio 1.77, 95% confidence interval 1.41 to 2.23). The risk of venous thromboembolism was increased during the whole pregnancy (P<0.001) and differed between the trimesters (P=0.002). The risk was particularly increased during the first trimester, at 1.5/1000 after in vitro fertilisation versus 0.3/1000 (hazard ratio 4.22, 2.46 to 7.26). The proportion of women experiencing pulmonary embolism during the first trimester was 3.0/10,000 after in vitro fertilisation versus 0.4/10,000 (hazard ratio 6.97, 2.21 to 21.96). CONCLUSIONS: In vitro fertilisation is associated with an increased risk of pulmonary embolism and venous thromboembolism during the first trimester. The risk of pulmonary embolism is low in absolute terms but because the condition is a leading cause of maternal mortality and clinical suspicion is critical for diagnosis, an awareness of this risk is important. TRIAL REGISTRATION: ClinicalTrials.gov NCT01524393.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.e8632

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Adverse outcomes may be even more pronounced among women with a lower reserve, including those with pre-existing excess CV risk or frank CVD.

    “Adverse outcomes may be even more pronounced among women with a lower reserve, including those with pre-existing excess CV risk (20) or frank CVD (21).”

    From Cardiovascular Risk Following Fertility Therapy (2017) · cites this paper as [20]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Henriksson, P., Westerlund, E., Wallen, H., Brandt, L., Hovatta, O., & Ekbom, A.
Affiliations
  • Danderyds sjukhus (SE)
  • Karolinska Institutet (SE)
Corresponding author
Henriksson, P.
Venue
BMJ
Publisher
BMJ
Published
2013-01-15
Volume
346
Issue
jan15 3
Pages
e8632-e8632
ISSN
1756-1833 (ISSN-L)
OpenAlex
W1968036356
Cited by
180
References
39
Citations by year
2026: 8 · 2025: 9 · 2024: 9 · 2023: 15 · 2022: 13 · 2021: 13 · 2020: 13 · 2019: 13 · 2018: 20 · 2017: 11 · 2016: 10 · 2015: 16 · 2014: 20 · 2013: 10
FWCI
16.35
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • BMJ (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
Keywords
pulmonary embolism, venous thromboembolism, in vitro fertilization, pregnancy, first trimester, thromboembolic risk, maternal mortality, assisted reproduction
MeSH terms
Adult, Cross-Sectional Studies, Female, Fertilization in Vitro, Humans, Middle Aged, Pregnancy, Pregnancy Trimester, First, Pulmonary Embolism, Registries, Risk Factors, Sweden, Multivariate Analysis, Proportional Hazards Models, Venous Thromboembolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review